one step at a time….immune therapy for prostate cancer is becoming hotter!
first U.S. patients dosed in expanded... - Advanced Prostate...
first U.S. patients dosed in expanded Phase 1b clinical trial of CB307 for patients with mCRPC
![Maxone73 profile image](https://images.hu-production.be/avatars/cc6cfcd066d747309f3dc14136bd6475_small@2x_100x100.jpg)
Written by
![Maxone73 profile image](https://images.hu-production.be/avatars/cc6cfcd066d747309f3dc14136bd6475_small@2x_100x100.jpg)
Maxone73
To view profiles and participate in discussions please or .
Read more about...
2 Replies
•
thanks for the info as it looks promising but still in early phase with a long way to go. Let’s hope it’s effective and less toxic to current immunotherapies.
Stay strong
Not what you're looking for?
You may also like...
PHASE 3 ECLIPSE STUDY FOR (MCRPC) PATIENTS- FIRST INFUSION OF Lutetium- 177
Just had my 1st infusion of Lutetium- 177, 3/9/23, in the Eclipse Trial.
Received 216.0 mCi of...
Veru Reports Positive Clinical Results from VERU-111 Phase 1b/2 Trial in Men with Metastatic Castration-Resistant Prostate Cancer, Advancing
This is what I was working on getting for my husband the day before he died last month. They're...
DES is As Effective As Lupron in Phase 3 Clinical Trial
I would like to try DES myself so I can take a vacation from Xtandi. If any of you guys know a...
New Drug BAY1841788 (ODM-201) has been successful for CRPC patients, Clinical trial Phase III completed.
This drug is for patients with Castration Resistance Prostate Cancer , apparently the clinical...
Tolerability and treatment response to darolutamide in patients with nmCRPC in the phase III ARAMIS trial
Darolutamide was well tolerated by most patients. Effectiveness related to the PSA decline from...